FORM 5

    


      


        
[__] Check box if no longer


                subject to Section 16. Form 4 or

          Form


                5 obligations may continue.


                See Instruction
1(b).


          


          [__]  Form 3 Holdings

          Reported


          [__]  Form 4 Transactions Reported

              



     UNITED STATES SECURITIES
      AND EXCHANGE COMMISSION


    Washington,
D.C.  20549


      ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP


      


    Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934, Section 17(a) of the Public
Utility


      Holding Company Act of 1935 or Section 30(h) of

      the Investment Company Act of 1940






    
OMB APPROVAL

    



      
OMB Number: 3235-0362

    
Expires: January 31,
2005
Estimated average burden


        hours per response. . . . 1.0













    
1. Name and Address of Reporting
Person*

      
   Needleman, Philip 

    


    
(Last)    
                 (First)
                   
 (Middle)




    


        
  100 Route 206 North

      



    


    
(Street)




    


        
  Peapack, NJ 07977

      

    


    
(City)    
                 (State)
                   
 (Zip)










    
2.
      Issuer Name and
Ticker
    or Trading Symbol



    
   Pharmacia - PHA

    


    
3. I.R.S.
Identification
    Number of
Reporting
    Person, if an
entity

            (Voluntary)
      


     





    
4. Statement for


            (Month/Year)

      


    
   12/2002

    


      
5. If Amendment,


            Date of Original


            (Month/Year)



		
    

        





    
6. Relationship of Reporting
Person(s) to Issuer

    
(Check all
applicable)




      

              

          __   Director  
                                  
          __   10% Owner


        


           X    Officer (give title below)
            
          __   Other (specify below)


        


        
    Senior Executive Vice President    

        

    


      
 7. Individual or Joint/Group Reporting
      
    (check applicable
        line)

    


      
  _ X _    Form Filed by One Reporting Person

      


      
  ____    Form Filed by

        More than One Reporting Person













    
Table I -
Non-Derivative Securities Acquired, Disposed of, or Beneficially
Owned








  

    

      
1. Title of Security


            (Instr. 3)

      


    

    

      
2. Transaction Date


            (Month/Day/Year)

    

     
2A. Deemed
     
      Execution


                Date,


              if any (Month/


              Day/ Year)


    

      
3. Transaction Code


            (Instr. 8)

      


    

    

      
4. Securities Acquired (A) or Disposed of
        (D)  

            (Instr. 3, 4 and 5)

    

    

      
5. Amount of


            Securities


            Beneficially


            Owned at the end of


            Issuer's Fiscal Year


            (Instr. 3 and 4)

    

    

      
6. Ownership


            Form:


            Direct (D)


            or Indirect (I)


            (Instr. 4)

    

    

      
7.   Nature of


             Indirect


             Beneficial


             Ownership


             (Instr. 4)

    

  

  
    Amount
    (A) or
      (D)
    Price
  
Common11/13/2002 G717D 198,005D Common      14,731ISavings Plan




* If the form is filed by more than one
reporting person, see Instruction 4(b)(v).











    
Table II -
Derivative Securities Acquired, Disposed of, or Beneficially
Owned

      
(e.g., puts, calls,
        warrants, options, convertible securities)








  

     
1. Title
of Derivative

        Security


            (Instr. 3)

     
2. Conver-


            sion or


            Exercise


            Price of


            Deri-


            vative


            Security

     
3. Transaction


            Date  (Month/


            Day/ Year)

     
3A. Deemed


              Execution Date,


              if any (Month/


              Day/ Year)

     
4.
Transaction Code

            

            (Instr. 8)

     
5. Number
        of

            Derivative

            Securities 

            Acquired (A)

            or Disposed of (D)

            (Instr. 3, 4 and 5)

     
6. Date
Exercisable

        and


            Expiration Date


            (Month/Day/Year)

     
7. Title
and Amount


            of  Underlying


            Securities


            (Instr. 3 and 4)

     
8. Price of


            Derivative


            Security

            (Instr. 5)

           
9. Number of


            Derivative


            Securities


            Beneficially


            Owned


            at End of
    Year


            (Instr. 4)

               
10. Ownership of
     Derivative
     Security:
      


              Direct (D)


             or Indirect (I)


             (Instr. 4)






     
11. Nature of


              Indirect


              Beneficial


              Ownership

              (Instr. 4)

  
  

    (A)
    (D)
    Date

      Exercisable
    Expiration

      Date
    Title
    Amount or

      Number of
Shares

               






  
    
Explanation
        of Responses:    

        

         
  
  
     
                  /s/ Don W. Schmitz, attorney-in-fact for Philip Needleman                 
       01/24/2003   
  
  
    ** Signature of
      Reporting Person
    Date 
    
  
  
    

      

      ** Intentional misstatements or omissions of facts constitute Federal Criminal
      Violations.

              See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

      

      Note:   File three copies of this Form, one of which must be manually
      signed. If space is insufficient,

                  see Instruction 6 for procedure.